Revenue from Contracts with Customers

9 Months Ended

Sep. 30, 2023

Revenue from Contract with Customer [Abstract]

Revenue from Contracts with Customers

3.   Revenue from Contracts with Customers. We recognize revenue when a customer obtains control of promised goods. The amount of revenue recognized reflects the consideration we expect to receive in exchange for these goods. Our revenue recognition policies have not changed from those disclosed in Note 1 to our consolidated financial statements in Item 8 of the 2022 Annual Report on Form 10-K.

Disaggregation of Revenue

Our revenue is disaggregated based on reporting segment, product category and geographical region. We design, develop, manufacture and market medical products for interventional and diagnostic procedures. For financial reporting purposes, we report our operations in two operating segments: cardiovascular and endoscopy. Our cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer (“OEM”). Within these product categories, we sell a variety of products, including cardiology and radiology devices (which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases), as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, and interventional oncology and spine devices. Our endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.

The following tables present revenue from contracts with customers by reporting segment, product category and geographical region for the three and nine-month periods ended September 30, 2023 and 2022 (in thousands):

	Three Months Ended						Three Months Ended
	September 30, 2023						September 30, 2022
	United States		International		Total		United States		International		Total
Cardiovascular
Peripheral Intervention	$	78,617	$	49,768	$	128,385	$	67,200	$	43,498	$	110,698
Cardiac Intervention		36,593		52,513		89,106		33,194		53,654		86,848
Custom Procedural Solutions		29,602		19,022		48,624		27,078		18,614		45,692
OEM		34,207		5,762		39,969		29,425		6,286		35,711
Total		179,019		127,065		306,084		156,897		122,052		278,949
Endoscopy
Endoscopy Devices		8,486		660		9,146		7,674		552		8,226
Total	$	187,505	$	127,725	$	315,230	$	164,571	$	122,604	$	287,175

	Nine Months Ended						Nine Months Ended
	September 30, 2023						September 30, 2022
	United States		International		Total		United States		International		Total
Cardiovascular
Peripheral Intervention	$	219,257	$	148,820	$	368,077	$	195,095	$	132,331	$	327,426
Cardiac Intervention		106,588		161,621		268,209		95,652		162,257		257,909
Custom Procedural Solutions		85,556		60,153		145,709		80,951		60,096		141,047
OEM		101,341		21,999		123,340		87,269		18,904		106,173
Total		512,742		392,593		905,335		458,967		373,588		832,555
Endoscopy
Endoscopy Devices		25,705		1,811		27,516		23,270		1,741		25,011
Total	$	538,447	$	394,404	$	932,851	$	482,237	$	375,329	$	857,566